Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“PDAP1 pseudogene 2” (PDAP1P2) does not match a recognized protein-coding gene, characterized molecular target, or established therapeutic target. The primary characterized molecule is PDGFA-associated protein 1 (PDAP1), also known as HAP28, a conserved phosphoprotein involved in processes such as B cell homeostasis, cancer cell proliferation, and interaction with PDGFA/PDGFB[1][2][3]. However, ‘PDAP1 pseudogene 2’ refers instead to a pseudogene, which by definition is a non-functional, non-coding genetic element resembling PDAP1. Pseudogenes do not produce functional proteins and are generally not considered therapeutic targets, in contrast to the canonical PDAP1 protein[3]. No biological functions, disease associations, pharmacological interactions, mechanisms of action, or known biomarkers or safety concerns are established for “PDAP1 pseudogene 2.” If you intend to refer to the functional molecule, use “PDGFA-associated protein 1 (PDAP1)” instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDAP1 pseudogene 2 (PDAP1P2).